AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Meeting Demand for Successful Drugs
The success of ZEPBOUND has led to organic demand, causing shortages at Eli Lilly. To address the high demand, the company plans to start marketing the drug in the U.S. and globally, starting with Europe. However, building new plants to meet the demand is a time-consuming process, taking around three to four years per plant. Despite supply being a challenge, other factors like price, insurance gaps, and body acceptance debates also affect the accessibility of these drugs.